Jim Simons Imv Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.47 - $0.75 $41,883 - $66,834	89,113 Added 680.25%	102,213 $53,000
Q2 2022 Aug 12, 2022	BUY	$0.56 - $1.45 $7,336 - $18,995	13,100 New	13,100 $9,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $1.78 $31,476 - $45,924	-25,800 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.35 - $2.16 $8,235 - $13,176	-6,100 Reduced 19.12%	25,800 $43,000
Q2 2021 Aug 13, 2021	BUY	$2.12 - $3.24 $67,628 - $103,356	31,900 New	31,900 $70,000
Q1 2021 May 13, 2021	SELL	$2.92 - $4.41 $321,492 - $485,541	-110,100 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.9 - $4.4 $266,800 - $404,800	92,000 Added 508.29%	110,100 $338,000
Q3 2020 Nov 13, 2020	SELL	$2.87 - $5.95 $18,655 - $38,675	-6,500 Reduced 26.42%	18,100 $80,000
Q2 2020 Aug 13, 2020	BUY	$1.52 - $3.63 $37,392 - $89,298	24,600 New	24,600 $77,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.